1,135
Views
4
CrossRef citations to date
0
Altmetric
Case Reports

Isolated renal intravascular lymphoma: a case report and review of the literature

, , , , &
Pages 1125-1128 | Received 08 Jan 2014, Accepted 23 Apr 2014, Published online: 15 May 2014

Figures & data

Figure 1. (a, b) FDG-PET-CT images depicting diffuse FDG accumulation in both kidneys with a SUVmax of 13.80.

Figure 1. (a, b) FDG-PET-CT images depicting diffuse FDG accumulation in both kidneys with a SUVmax of 13.80.

Figure 2. Renal biopsy revealed lymphoma cells in arterioles, venules and capillaries (H&E).

Figure 2. Renal biopsy revealed lymphoma cells in arterioles, venules and capillaries (H&E).

Figure 3. Renal biopsy revealed CD20 (+) lymphoma cells in renal arterioles, venules and capillaries.

Figure 3. Renal biopsy revealed CD20 (+) lymphoma cells in renal arterioles, venules and capillaries.

Table 1. Baseline biochemical data of the patient (BUN: blood urea nitrogen, LDH: lactate dehydrogenase, GGT: gamma-glutamyltransferase, ALT: alanine aminotransferase, AST: aspartate aminotransferase, WBC: white blood cell, PMNL: polymorphonuclear cells, LYM: lymphocytes, PLT: platelets, ESR: erythrocyte sedimentation rate, hs-CRP: high-sensitive C-reactive protein).

Table 2. Summary of the clinical features, treatments and outcomes of the IVLBCL cases involving the kidneys (CAVP: cyclophosphamide, doxorubicin, vincristine, prednisone, R-CHOP: rituximab, cyclophosphamide, Adriamycin, vincristine and prednisolone, AKI: acute kidney injury, VACOP-B: etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, bleomycin, LAP: lymphadenopathy).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.